Novel CDKN2A mutations in Austrian melanoma patients

Area of Science:

• Genetics
• Oncology
• Dermatology

Background:

• Familial melanoma is strongly linked to the CDKN2A gene, with mutations found in up to 40% of affected families.
• Numerous CDKN2A mutations are known, including regional founder mutations, highlighting the need for population-specific genetic studies.

Purpose of the Study:

• To identify germline mutations in the CDKN2A gene within the Austrian population for the first time.
• To detect novel CDKN2A mutations and assess their potential risk for melanoma development.

Main Methods:

• Sanger sequencing of CDKN2A exons 1α, 1β, and 2 in 700 Austrian individuals across different risk groups (high-risk patients, single primary melanoma patients, and healthy controls).
• Sequencing of CDK4 exon 2 in 136 patients with a family history of melanoma.
• Computational effect prediction analysis for identified mutations of unknown significance.

Main Results:

• The disease-associated mutation p.R24P was identified as the most common high-risk mutation in Austria.
• Four mutations of unknown significance were discovered, including two novel mutations: p.A34V and c.151-4 G>C.
• Computational analysis suggested p.A34V confers a high melanoma risk, while c.151-4 G>C's functional impact on splicing remains unconfirmed.

Conclusions:

• Germline mutations in CDKN2A are present in Austrian melanoma patients, with p.R24P being the predominant high-risk mutation.
• The discovery of novel mutations p.A34V and c.151-4 G>C contributes to the understanding of melanoma genetics in Austria.
• These findings support the importance of genetic screening for CDKN2A mutations in individuals with a history of melanoma or familial predisposition.